Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
RELMADA THERAPEUTICS, INC. See All Filings	D	2019-10-08 16:41:38 UTC
Amount To Be Raised $825,750 Associated Brokers / Dealers None CIK Number 0001553643 Filed Document 0001213900-19-019994 Exclusions or Exemptions 506b Accepted Date 2019-10-08 16:41:38 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D/A	2019-07-10 16:27:11 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Alexander Capital, LP and Brookline Capital Markets, A division of Arcadia Securities, LLC CIK Number 0001553643 Filed Document 0001213900-19-012436 Exclusions or Exemptions 506b Accepted Date 2019-07-10 16:27:11 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D	2019-06-27 16:30:57 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Alexander Capital, LP and Brookline Capital Markets, A division of Arcadia Securities, LLC CIK Number 0001553643 Filed Document 0001213900-19-011648 Exclusions or Exemptions 506b Accepted Date 2019-06-27 16:30:57 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D	2019-05-16 16:12:56 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Alexander Capital, LP and Brookline Capital Markets, A division of CIM Securities, LLC CIK Number 0001553643 Filed Document 0001213900-19-009006 Exclusions or Exemptions 506b Accepted Date 2019-05-16 16:12:56 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D/A	2018-12-10 16:39:00 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001553643 Filed Document 0001213900-18-017157 Exclusions or Exemptions 506b Accepted Date 2018-12-10 16:39:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D/A	2018-11-13 13:41:50 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001553643 Filed Document 0001213900-18-015444 Exclusions or Exemptions 506b Accepted Date 2018-11-13 13:41:50 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D	2018-10-22 13:12:05 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001553643 Filed Document 0001213900-18-014204 Exclusions or Exemptions 506b Accepted Date 2018-10-22 13:12:05 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
RELMADA THERAPEUTICS, INC. See All Filings	D	2017-10-06 10:18:43 UTC
Amount To Be Raised $6,890,000 Associated Brokers / Dealers Alexander Capital, LP CIK Number 0001553643 Filed Document 0001213900-17-010345 Exclusions or Exemptions 506b Accepted Date 2017-10-06 10:18:43 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Debt
CAMP NINE, INC. See All Filings	D	2014-06-19 00:00:00 UTC
Amount To Be Raised $10,694,588 Associated Brokers / Dealers Laidlaw & Company (UK) Ltd. CIK Number 0001553643 Filed Document 0001213900-14-004304 Exclusions or Exemptions 506b Accepted Date 2014-06-19 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity
CAMP NINE, INC. See All Filings	D	2014-06-03 00:00:00 UTC
Amount To Be Raised $0 Associated Brokers / Dealers N/A CIK Number 0001553643 Filed Document 0001213900-14-003956 Exclusions or Exemptions 506b Accepted Date 2014-06-03 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets $No Revenues Type of Security Equity